News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tivorsan Pharmaceuticals, Inc.' Biglycan for Duchenne Muscular Dystrophy Named One of Windhover Information Inc.'s Top 10 “Hot Space” Projects to Watch



10/19/2011 10:34:38 AM

PROVIDENCE, R.I.--(BUSINESS WIRE)--Tivorsan Pharmaceuticals, Inc., a privately held biotechnology company developing a novel protein therapeutic to combat Duchenne Muscular Dystrophy (DMD), has been selected as one of 2011’s Windhover’s Top 10 Most Interesting “Hot Space” Projects to Watch.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES